Associated Papers
Genetic alterations predict poor efficacy, outcomes and resistance to second-line osimertinib treatment in non-small cell lung cancer.
Bai H et al.
American Journal of Cancer Research, 2024
Pemetrexed induces ROS generation and cellular senescence by attenuating TS-mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC.
Chen Y et al.
Journal of Cellular and Molecular Medicine, 2023
Select a paper to view details